Abiraterone acetate for early stage metastatic prostate cancer: patient selection and special considerations

Castellan P, Marchioni M, Castellucci R, De Francesco P, Iantorno R, Schips L, Cindolo L

Therapeutics and Clinical Risk Management 2018, 14:2341-2347

Published Date: 6 December 2018